| MYB |
MYB: Myb proto-oncogene protein |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
0.265 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| COL4A1 |
IPI00021034 |
THBD |
THBD, THRM: Thrombomodulin precursor |
0.265 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
|
| IGFBP3 |
IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor |
LUM |
LUM, LDC: Lumican precursor |
0.265 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
0.265 |
Evidence |
|
| BRPF1 |
BRPF1, BR140: Peregrin |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
| THBD |
THBD, THRM: Thrombomodulin precursor |
NOTCH3 |
NOTCH3: Neurogenic locus notch homolog protein 3 precursor |
0.265 |
Evidence |
|
| ADAM19 |
ADAM19, MLTNB, FKSG34: ADAM 19 precursor |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| MATR3 |
MATR3, KIAA0723: Matrin-3 |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
0.265 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
ALB |
ALB: Uncharacterized protein ALB |
0.265 |
Evidence |
|
| NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.265 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.265 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.265 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
IGFBP6 |
IGFBP6, IBP6: Insulin-like growth factor-binding protein 6 precursor |
0.265 |
Evidence |
|
| NAGPA |
NAGPA: N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase precur |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CDK4 |
CDK4: Cell division protein kinase 4 |
0.265 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| CENPA |
CENPA: Histone H3-like centromeric protein A |
GNB2L1 |
Lung cancer oncogene 7 |
0.265 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
0.265 |
Evidence |
|
| MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
RDX |
RDX: Radixin |
0.265 |
Evidence |
|
- 
- 
-